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Abstract 
 
Human-derived pharmaceuticals have been identified entering surface waters in 
the United States through wastewater effluent. While there is ample literature about what 
each compound alone does to aquatic life, little is known about the effects aquatic life 
may experience from the exposure to many different pharmaceuticals present in the 
environment. More specifically, are the combination of pharmaceuticals in the 
environment more detrimental to aquatic life than each pharmaceutical alone?  
Zebrafish embryos were used to model what aquatic life in Lake Champlain may 
experience. Vatovec et al (2016) determined that there are 51 environmentally-relevant 
human derived pharmaceuticals entering Lake Champlain through wastewater effluent. 
Out of the 51, acetaminophen, carbamazepine, and diphenhydramine were studied. 
Embryos were exposed to each pharmaceutical for three days at various concentrations 
and observed for any developmental defects.  The sub-lethal concentration of each 
pharmaceutical was determined and then this specific concentration was used in 
subsequent combination experiments.   
Results indicated that the exposure to all three pharmaceuticals were more 
detrimental to embryonic development than each pharmaceutical alone. However, when 
pharmaceuticals were combined in groups of two, one of the groups was more 
detrimental to embryos than the combination of all three pharmaceuticals.  
Although concentrations used in this experiment were much higher than that found in the 
environment, the implications of this study are still important. It is necessary to determine 
and demonstrate at what concentration pharmaceuticals are detrimental to aquatic life so 
that environmental concentrations never reach the concentrations used in the current 
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experiment. The outcome of this research stands as a warning as to what may occur if 
nothing is done about pharmaceuticals entering water sources. Future studies should 
determine combination effects of pharmaceuticals at environmental concentrations. 
Keywords 
Zebrafish embryo, Toxicity, pharmaceuticals, Lake Champlain 
1. Introduction 
Recently, there has been an increased effort to understand the extent to which 
human-derived pharmaceuticals, which are made to elicit a physiological response in 
humans, animals, and plants, are entering water sources and how these pharmaceuticals 
may affect our environment (Kolpin et al., 2002). In 2002, Kolpin et al. provided the first 
nationwide surveillance, which determined pharmaceuticals, hormones, and other organic 
wastewater contaminants are in fact entering streams in the United States. 
Pharmaceuticals have been permeating water sources through incorrect disposal of left-
over drugs, agricultural run-off (Ferguson, Bernot, Doll, & Lauer, 2013), and excretion of 
active ingredients or metabolites after use in humans (Grabicova et al., 2014). These 
active ingredients or metabolites subsequently reach water treatment systems with 
outdated technology that is not equipped to filter the pharmaceuticals used in healthcare 
today (Daughton, 2003). 
        Many studies have been performed to increase understanding of the effects of 
single acute exposure to a pharmaceutical. One drug that has been studied in particular is 
the antidepressant fluoxetine because it has been identified in municipal effluents 
(Brooks et al., 2003). Brooks et al. (2003) found that the environmental concentration of 
fluoxetine was not acutely toxic to aquatic life and that the lowest measured fluoxetine 
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effect levels were at an order of magnitude higher than the highest reported municipal 
effluent concentrations. Brandhof & Montforts (2010) tested acute exposure of 
carbamazepine (anticonvulsant), diclofenac (anti-inflammatory) and metoprolol (beta 
blocker for hypertension), and showed that zebrafish embryos had developmental 
abnormalities such as heart deformation, growth retardation, and scoliosis when exposed 
to these drugs at higher concentrations than present in the environment. 
Concentrations of pharmaceuticals in the environment are generally low and do 
not surpass drinking water guidelines or aquatic life criteria (Kolpin et al., 2002). 
However, Koplin et al. (2002) highlights the need for creating guidelines for substances 
that do not have them. In addition, organisms in the environment are generally not 
exposed to these pharmaceutical agents in isolation, but in combination. Thus, Koplin et 
al. (2002) also emphasizes the need for determining any combination effects that these 
substances may have on aquatic life, which is vital to protect the environment and, 
ultimately, human health. 
Cleuvers (2003) tested the effects of mixtures of pharmaceuticals on aquatic life. 
The results showed that tests with a combination of two pharmaceuticals revealed 
stronger effects on Daphnia manga, Desmodesmus subspicatus, and Lemna minor in 
comparison with pharmaceuticals that were tested separately (Cleuvers, 2003). The goal 
of the current study is to expand upon these findings by examining the combination of 
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Table 1. Pharmaceuticals that were studied  
Vatovec et al. (2016) found that there are 51 pharmaceuticals in 80% or more of 
wastewater effluent entering Lake Champlain. Of these 51 environmentally relevant 
pharmaceuticals, three were used in this experiment: carbamazepine, diphenhydramine, 
and acetaminophen (Table 1). The pharmaceuticals do not have the same mode of action 
and do not have any known interactions. However, it is still important to understand 
mixture toxicities of drugs that do not interact, as aquatic organisms in the environment 
are not only exposed to pharmaceuticals with known drug interactions. These three 
pharmaceuticals were selected as a result of their prevalence in the literature. They have 
been identified in a variety of water sources in the United States and their effects on 
aquatic life are beginning to be better understood.  When interpreting results, there are 
ample resources to compare results of the experiment to those in the literature. They were 
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also selected because of personal interest. In addition, the prices of the pharmaceuticals 
selected were within our budget.  
Carbamazepine is an anticonvulsant and is thought to act by reducing 
polysynaptic responses and blocking post-tetanic potentiation. The drug also has some 
analgesic effects. Carbamazepine, or Tegretol, is used to treat seizures due to epilepsy 
and pain due to trigeminal neuralgia (Novartis Pharmaceuticals Corporation, 2009).  
Diphenhydramine (DPH) is an antihistamine with sedative and anticholinergic 
effects. Diphenhydramine is thought to act by competing with histamines for cell receptor 
sites on effector cells. DPH, is used to reduce allergic reactions to blood or plasma or 
during anaphylaxis. It is also used to treat motion sickness and parkinsonism (US Food 
and Drug Administration, 2013).  
Acetaminophen is an analgesic and an antipyretic. It is one of the most widely 
used medicines in the United States 24.6 billion doses were sold alone in 2008 (Dal Pan, 
2009). Acetaminophen is thought to work by inhibiting prostaglandin H synthase 
(Boutaud et al, 2002). It is found in many prescriptions and in many over the counter 
medicines used to treat cold and flu symptoms (Dal Pan, 2009).  
Zebrafish, Danio rerio, served as the model organism for this study. This species 
has been used as a model organism in developmental biology and molecular genetics and 
more recently, toxicology. Using zebrafish to study toxicity is valuable because more is 
known about normal developmental milestones and parameters in zebrafish than any 
other fish species. This makes it particularly straightforward for studying any 
abnormalities that may occur due to toxicity exposure (Hill et al., 2005). Researchers 
have identified and understand morphological, biochemical, and physiological processes 
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at all stages of early development, adolescent, and both sexes of the adult fish (Hill et al., 
2005). 
Apart from the in-depth knowledge that is available about normal development in 
the zebrafish, the species is a great model organism for toxicology studies for many other 
reasons. Zebrafish are approximately 1-1.5 inches in length. This small size reduces 
housing needs and husbandry costs compared to other fish used as model organisms such 
as trout. Since larvae and adults are small less drug is needed to make dosing solutions. 
This helps to reduce waste accumulation during an experiment. Adult zebrafish have a 
high fecundity and can often lay 200-300 embryos every five to seven days. Lastly, 
zebrafish embryos are also transparent. This makes it easy for the observer to notice any 
phenotypic abnormalities that may result from drug toxicity screening (Hill et al., 2005). 
Understanding combination effects of pharmaceuticals on developing embryos is 
extremely important for a variety of reasons. Pharmaceuticals entering water sources 
through wastewater effluent have the ability to disrupt the environment. As of right now, 
many of the pharmaceutical concentrations in water sources are not acutely toxic to 
aquatic life. However, combination effects must be considered and chronic exposure over 
multiple generations is of concern. Even if only small organisms are affected by 
pharmaceutical exposure, the impact of pharmaceuticals entering water sources could be 
detrimental to local ecosystems and eventually the environment.  
In this study we hypothesized that exposure to the combination of 
pharmaceuticals will be more detrimental to zebrafish embryo development than 
exposure to a single pharmaceuticals alone. One objective of the experiment was to 
determine the sub-lethal concentrations of the three drugs that results in developmental 
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abnormalities. The second objective was to determine the combination effects of the three 
drugs on developing embryos based upon these sub-lethal concentrations. With these 
objectives completed, there will be a better understanding of what may actually be 
happening in the environment, as these human derived pharmaceuticals are not isolated 
from one another.   
 
2. Methods 
 The pharmaceuticals (i.e., drugs) that were studied were obtained from Sigma-
Aldrich, Carbamazepine (C4024), Acetaminophen (A7085), and Diphenhydramine 
(D3630). Zebrafish embryos were provided by the Ebert Laboratory and all procedures 
were approved by the University of Vermont Institutional Animal Care and Use 
Committee (IACUC) protocol #12-055. 
Zebrafish embryos were collected by removing a set of adults, which consists of 
two males and three females, from their tanks and placing the zebrafish in spawning 
tanks that consist of a lid and an insert that has holes so that the embryos can fall through 
and be separated from the adult fish. The males and females were then separated in the 
tank by an insert overnight and released in the morning to spawn in shallow water. The 
embryos were placed into egg water and subsequently transferred to 24–well dishes for 
their treatments. Treatments began directly following fertilization to mimic 
environmental conditions. 
To test each drug for lethal and sub-lethal concentrations ten embryos were placed 
in a well with 1 mL of 100% egg water to act as the control, ten embryos were placed in 
each well with a drug concentration of 0.05 mg/mL (Treatment 1, T1), 0.1 mg/mL 
(Treatment 2, T2), 0.2 mg/mL (Treatment 3, T3), and 0.4 mg/mL (Treatment 4, T4). This 
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method was replicated three times for carbamazepine and diphenhydramine and two 
times for acetaminophen, using a different batch of embryos in each replication. When 
testing carbamazepine, the control solution consisted of egg water that is 1% Dimethyl 
Sulfoxide (DMSO) as carbamazepine is insoluble in water. Each treatment was dissolved 
in 1% DMSO along with the appropriate drug concentration. 
An important breakthrough was discovered when testing with acetaminophen. 
Instead of placing ten embryos in each well, five embryos were placed in each well. The 
number was reduced because when testing for developmental abnormalities in embryos 
exposed to acetaminophen, the embryos were all dead at day two of the experiment. 
Therefore, the number of embryos in each well was reduced as the embryos may have 
been dying from hypoxia due to the number of embryos in 1 mL of solution. This new 
technique was also used when testing for developmental abnormalities in embryos 
exposed to diphenhydramine and it was used in all combination treatments.  
After 24 hours of treatment, embryos were manually dechorionated and were 
observed daily at 24 hours post fertilization (hpf), 48 hpf, and 72 hpf under a dissecting 
microscope. Pictures were taken with SPOT software on a Nikon dissecting microscope 
to document any and all abnormalities of the treatment groups in comparison to the 
control group. In addition, spontaneous tail movements of the embryos at 24 hpf were 
studied when testing for developmental abnormalities that may be associated with 
diphenhydramine exposure because the drug has some sedative effects. To determine if 
spontaneous movement was affected, each of the control embryos and each of the embryo 
undergoing diphenhydramine treatments were observed under a microscope for one 
minute at day one (18-26 hours post-fertilization) (Huang et al., 2010). The number of 
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times each embryo bends its tail was then recorded. At 72 hpf, eye size was noticeably 
smaller for embryos exposed to 0.4 mg/mL of acetaminophen. Therefore, SPOT software 
was used to determine the area (µm2) of each eye from photographs.  
Sub-lethal concentrations of each separate drug were established at 72 hpf, based 
upon which treatment concentration exhibited the most phenotypic abnormalities without 
killing all embryos. These concentrations were then combined into 1 mL of egg water 
containing 1% DMSO. There was a control well of 1% DMSO in egg water with five 
embryos, and a treatment well of the mixture and five embryos. This treatment was 
replicated once as only one clutch of embryos was used.  Again, after 24 hours of 
treatment, embryos were dechorionated and were observed at 24 hpf, 48 hpf, and 72 hpf 
using a dissecting microscope. Developmental abnormalities were recorded using SPOT. 
Spontaneous tail movements were recorded for day one of the experiment (18-28 hpf) 
and eye size was recorded at 72 hpf. 
After the combination effects of all three pharmaceuticals were observed and 
documented, a treatment with the sub-lethal concentrations of diphenhydramine and 
acetaminophen was conducted. This treatment was replicated twice. A treatment with the 
sub-lethal concentrations of diphenhydramine and carbamazepine and a treatment with 
the sub-lethal concentrations of acetaminophen and carbamazepine were also conducted. 
These treatments were each replicated once. Likewise, after 24 hours of treatment, 
embryos were manually dechorionated and observed at 24 hpf, 48 hpf, and 72 hpf using a 
dissecting microscope. SPOT software was used to photograph any developmental 
abnormalities seen. Spontaneous tail movements were recorded at day one of the 
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experiment for any treatment that contained diphenhydramine. Eye size was recorded at 
72 hpf for any treatment that contained acetaminophen.  
Results were organized into line graphs and tables. Percent wild-type over 72 
hours was displayed in a line graph for each drug and drug combinations. In tables, 
results were organized into percent wild-type, percent mild (one abnormality), percent 
moderate (two abnormalities), percent serious (three abnormalities), percent severe (4 or 
more abnormalities), and percent dead. Phenotypic abnormalities were further organized 
by reporting percent of specific phenotypes seen at 72 hpf, such as edema, tail 
deformities, spine deformities, etc, for sub-lethal concentrations of each drug and 
subsequent combination treatments. An unpaired t-test was used to determine differences 
in eye size from T4 (0.4mg/mL) acetaminophen treatment. A multiple comparisons one 
way ANOVA was used to compare eye size in T4 of acetaminophen versus combination 
treatments that included acetaminophen. A multiple comparisons one way ANOVA was 
used to compare the frequency of tail bends across the controls and all treatments of 
diphenhydramine. Again, a multiple comparisons one way ANOVA was then used to 
compare the diphenhydramine treatment concentration that was eventually chosen for 




















Graph 1: Percent of wild type zebrafish embryos over time exposed to four different 
treatments of acetaminophen.  
Phenotypic	  Categories	  in	  Acetaminophen	   	  	   	  	   	  	  
hpf	   %WT	   %mild	   %moderate	   %serious	   %severe	   %dead	  
Controls	   	  	   	  	   	  	   	  	   	  	   	  	  
24	   100	   0	   0	   0	   0	   0	  
48	   82.14	   3.57	   14.28	   0	   0	   0	  
72	   71.43	   10.71	   3.57	   0	   0	   14.29	  
T1	  (0.05mg/mL)	   	  	   	  	   	  	   	  	   	  	  
24	   100	   0	   0	   0	   0	   0	  
48	   100	   0	   0	   0	   0	   0	  
72	   100	   0	   0	   0	   0	   0	  
T2	  (0.1mg/mL)	   	  	   	  	   	  	   	  	   	  	  
24	   100	   0	   0	   0	   0	   0	  
48	   93.33	   6.66	   0	   0	   0	   0	  
72	   93.33	   6.66	   0	   0	   0	   0	  
T3	  (0.2mg/mL)	   	  	   	  	   	  	   	  	   	  	  

















Hours	  post	  ferilization	  (hpf)	  
Acetaminophen	  
Control	  N=2	  n=28	  T1	  0.05mg/mL	  N=2	  n=26	  T2	  0.1mg/mL	  N=2	  n=30	  T3	  0.2mg/mL	  N=2	  n=27	  T4	  0.4mg/L	  N=2	  n=27	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48	   70.37	   29.63	   0	   0	   0	   0	  
72	   74.07	   25.93	   0	   0	   0	   0	  
T4	  (0.4mg/mL)	   	  	   	  	   	  	   	  	   	  	  
24	   82.76	   17.24	   0	   0	   0	   0	  
48	   14.81	   77.78	   7.41	   0	   0	   0	  
72	   0	   59.26	   14.81	   25.93	   0	   0	  
Table 1: Percent of wild type zebrafish embryos in different acetaminophen treatments 
over the course of three days. 
 
At 24 hours post fertilization (hpf) the control group, T1, and T2 had 100% wild 
type zebrafish embryos. There were no developmental abnormalities present. However, at 
24 hpf for T3 and T4, the percent wild-type was 70.96% and 82.76% respectively (Table 
1). As of day one, T3 and T4 had the most detrimental effects on zebrafish development 
with 29.03% of embryos with mild phenotypes and 17.24% of embryos with mild 
phenotypes, respectively. At 48 hpf the percent wild type of the control group decreased 
while the percent wild type in T1 remained constant. The percent wild-type decreased in 
T2 and only slightly in T3. However, the percent wild type drastically decreased in T4. 
At 72 hpf the percent wild type of  T1 and T2 remained constant, but the control group 
decreased in percent wild type and 14.29% of the embryos in the control group were 
dead. The percent wild type in T3 increased slightly while the percent wild type in T4 
dropped to 0% (Table 1). Overall, percent wild type remained fairly steady over the 
course of three days in the control, T1, T2, and T3 groups. T4 offered the most drastic 
decrease in percent wild type by day three (See Graph 1), thus the concentration in T4 
(0.4mg/mL) was used in subsequent combination experiments.  
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Figure 1: Image of the most common phenotype seen (small eyes) in T4 of acetaminophen 
at 72 hpf. 
 
In T4 at 72 hpf 85.19% of embryos had small eyes, 40.74% had edema, and 



















Graph 2: Eye size differences at 72 hpf between controls and various treatments that 
included acetaminophen. Graph shows standard error of the mean bars. ANOVA multiple 
comparisons. 
 
 At 72 hpf eye size between the control and treatment 4 (0.4 mg/mL) embryos 






















































Control mean 55011.1 
µm2
1% DMSO control mean 
53396.0 µm2
T4 0.4mg/mL mean 
31596.0 µm2
A+C+D mean 31327.0 
µm2
A+D mean 27497.5 µm2
A+C mean 29996.4 µm2
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which showed that zebrafish embryo eyes were significantly smaller (P <0.0001) in 
treatment four than in the control group. A one-way ANOVA with multiple comparisons 
was then conducted on eye size data from the control, 1% DMSO control, T4, A+C+D, 
A+D, and A+C groups. Embryo eyes were significantly smaller in treatment 4 than in the 
1% DMSO control group (P value <0.0001, Graph 2). Differences in eye size were not 
significant between the control group and the 1% DMSO control. In addition, differences 
in eye size were not significant between T4 and A+C+D, T4 and A+D, T4 and A+C, 




Graph 3: Percent of wild type zebrafish embryos over time exposed to four different 




















Hours	  post	  fertilization	  (hpf)	  
Diphenhydramine	  
Control	  N=3	  n=22	  T1	  0.05mg/mL	  N=3	  n=21	  T2	  0.1mg/mL	  N=3	  n=21	  T3	  0.2mg/mL	  N=3	  n=22	  T4	  0.4mg/mL	  N=3	  n=23	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Phenotypic	  Categories	  in	  Diphenhydramine	   	  	   	  	   	  	  
hpf	   %WT	   %mild	   %moderate	   %serious	   %severe	   %dead	  
Controls	  	   	  	   	  	   	  	   	  	   	  	   	  	  
24	   100	   0	   0	   0	   0	   0	  
48	   90.48	   9.09	   0	   0	   0	   0	  
72	   90.9	   9.09	   0	   0	   0	   0	  
T1	  (0.05mg/mL)	   	  	   	  	   	  	   	  	   	  	  
24	   100	   0	   0	   0	   0	   0	  
48	   95.24	   4.76	   0	   0	   0	   0	  
72	   100	   0	   0	   0	   0	   0	  
T2	  (0.1mg/mL)	   	  	   	  	   	  	   	  	   	  	  
24	   90.48	   9.52	   0	   0	   0	   0	  
48	   90.48	   9.52	   0	   0	   0	   0	  
72	   100	   0	   0	   0	   0	   0	  
T3	  (0.2mg/mL)	   	  	   	  	   	  	   	  	   	  	  
24	   68.18	   31.81	   0	   0	   0	   0	  
48	   13.63	   81.82	   0	   0	   0	   0	  
72	   40.91	   45.45	   0	   0	   0	   13.63	  
T4	  (0.4mg/mL)	   	  	   	  	   	  	   	  	   	  	  
24	   78.26	   21.74	   0	   0	   0	   0	  
48	   13.04	   82.61	   4.35	   0	   0	   0	  
72	   4.35	   73.91	   4.35	   0	   0	   17.39	  
Table 2:  Percent of wild type zebrafish embryos in different diphenhydramine treatments 
over the course of three days. 
 
At 24 hpf the control and T1 were both 100 percent wild type. T3 had the lowest 
percent wild type at 68.18%, T4 had the second lowest at 78.26% and T2 had the third 
lowest at 90.48%. At 48 hpf all groups decreased in percent wild type except T2. T3 and 
T4 had comparable percent wild type at 13.63% and 13.04%, respectively. At 72 hpf the 
percent wild type in the control group remained the same. The percent wild type 
increased in T1, T2, and T3. In T4 the percent wild type decreased to 4.35%. By day 
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three of the experiment (72 hpf), T4 has the lowest percent wild type while T1 and T2 
had the highest at 100% (Table 2). In addition, T4 had the most drastic decrease in 
percent wild type while T1 and T2 stayed fairly stable (Graph 3). T4 had the highest 
percent mild, moderate and dead at 73.91%, 4.35%, and 17.39%, respectively. Therefore, 
treatment 4 concentration (0.4mg/mL) was used in subsequent combination experiments.  
Figure 2: Image of the most common phenotype seen (edema) in T4 of diphenhydramine 
at 72 hpf. 
 
At 72 hpf in T4 the embryos had the highest percent of edema at 69.57% and the 
highest percent of tail deformities at 8.70%. In addition, 4.35% of embryos in T4 at 72 

















































Spontanous movements of embryos under DPH
































1% DMSO mean 31.44
T1 0.05mg/mL mean 
14.52
T2 0.1mg/mL mean 12.40
T3 0.2mg/mL mean 11.77
T4 0.4mg/mL mean 1.68






Graph 4: Number of movements per minute in each DPH treatment group at 24 hpf. 
Graph shows standard error of the mean bars. ANOVA multiple comparisons. 
 
Spontaneous movements were recorded for each treatment group to better 
characterize the effect DPH exposure may have had on developing zebrafish embryos. 
An one way ANOVA multiple comparisons test was conducted. The difference in 
number of movements per minute was significantly different in the control group 
compared to the 1% DMSO control. Treatments 1, 2, and 3 all had significantly less 
movement than in the control group. The number of movements per minute was most 
significantly different in the control group compared to T4. Treatments 1, 2, 3, 4 all had 
significantly less movement than in the 1% DMSO control group. The difference in 
movement between T4 and treatments one, two, and three, was also significant. The 
difference in number of movements between T1, T2, and T3 were not significant (See 



































Spontanous movements of embryos under 
combinations containing
 DPH 
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Control mean 22.22 
1% DMSO control mean 
31.44




	   19	  
 
 
Graph 5: Number of movements per minute at 24 hpf in each combination group 
containing DPH compared to T4. ANOVA multiple comparisons. Graph shows standard 
error of the mean bars.  
 
 Differences between T4 and the combinations of A+C+D, A+D, and C+D were 
not significant. In addition, differences in tail movements were also not significant 
between A+C+D and A+D, A+C+D and C+D, and A+D and C+D (See Graph 5). 
Carbamazepine results: 	  	  	  	  	  	  	  	  	  
Graph 6: Percent of wild type zebrafish embryos over time exposed to four different 
treatments of carbamazepine.  
Phenotypic	  Categories	  in	  Carbamazepine	   	  	   	  	  
hpf	   %WT	   %mild	   %moderate	   %serious	   %severe	   %dead	  
1%	   DMSO	  
control	   	  	   	  	   	  	   	  	   	  	  
24	   100	   0	   0	   0	   0	   0	  
48	   95.24	   4.76	   0	   0	   0	   0	  
72	   97.62	   2.38	   0	   0	   0	   0	  
















Hours	  post	  fertilization	  (hpf)	  
Carbamazepine	  
1%	  DMSO	  Control	  N=3	  n=34	  T1	  0.05mg/mL	  N=3	  n=33	  T2	  0.1mg/mL	  N=3	  n=29	  T3	  0.2mg/mL	  N=3	  n=32	  T4	  0.4mg/mL	  N=3	  n=33	  
	   20	  
24	   82.86	   5.71	   11.43	   0	   0	   0	  
48	   90.91	   9.09	   0	   0	   0	   0	  
72	   51.52	   33.33	   6.06	   0	   0	   9.09	  
T2	  
(0.1mg/mL)	   	  	   	  	   	  	   	  	   	  	  
24	   83.33	   16.67	   0	   0	   0	   0	  
48	   44.83	   41.38	   3.45	   0	   3.45	   6.90	  
72	   37.93	   20.69	   3.45	   0	   0	   37.93	  
T3	  
(0.2mg/mL)	   	  	   	  	   	  	   	  	   	  	  
24	   79.41	   8.82	   5.88	   0	   5.88	   0	  
48	   3.23	   77.42	   12.90	   0	   0	   6.45	  
72	   0	   38.71	   25.81	   0	   0	   35.48	  
T4	  
(0.4mg/mL)	   	  	   	  	   	  	   	  	   	  	  
24	   65.63	   25	   0	   0	   9.38	   0	  
48	   0	   22.58	   61.29	   0	   9.68	   6.45	  
72	   0	   10.34	   31.03	   6.90	   3.45	   48.28	  
Table 3:  Percent of wild type zebrafish embryos in different carbamazepine treatments 
over the course of three days. 
 
 At 24 hpf the controls had 100% wild type. T1 and T2 were comparable at 
82.86% wild type and 83.33% wild type, respectively. T3 had the second lowest percent 
wild type of 79.41 at 24 hpf, while T4 had the lowest at 65.63%. At 48 hpf the controls 
decreased to 95.24% wild type, while T1 had increased to 90.91% wild type. T2, T3, and 
T4, all plummeted in percent wild type to 44.83%, 3.23%, and 0%, respectively. By 72 
hpf controls were at 97.62% wild type. T1 had 51.52% wild type and T2 had an even 
smaller percent wild type at 37.93%. Both T3 and T4 had 0% wild type at 72 hpf (Table 
3).  
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T2 was picked for the concentration used in subsequent combination experiments. 
Both T3 and T4 had 0% wild type at 72 hpf, but these treatments had a high percent of 
death at 35.48% and 48.28% respectively. Although T2 did have a higher percent of 
death at 37.93% compared to T3, T2 was picked for subsequent experiments before a 
proper sample size was reached due to time constraints. In the end, more trials were done 
to reach an appropriate sample size, which revealed that T3 should have been the 
concentration used in subsequent combination experiments (Table 3).  
 
Figure 3: Image of the most common phenotype seen (edema) in T2 of carbamazepine at 
72 hpf. 
 
At 72 hpf in T2 17.24% of embryos had edema. This was the most common 
phenotype seen in this treatment group. In addition to edema, 3.45% of embryos had tail 
deformities, spine deformities and were less pigmented. Figure 2 shows an edema.  
 


















Graph 7: Percent of wild type zebrafish embryos over time exposed to different 
combination treatments. 
Phenotype categories seen in A+C+D     
hpf %WT %mild  %moderate %serious %severe %dead 
24 88.46 11.54 0.00 0.00 0.00 0.00 
48 0.00 0.00 41.67 58.33 0.00 0.00 
72 0.00 0.00 41.67 0.00 0.00 58.33 
Phenotype categories seen in A+D     
hpf %WT %mild  %moderate %serious %severe %dead 
24 60.61 36.36 3.03 0.00 0.00 0.00 
48 0.00 0.00 22.22 18.52 25.93 33.33 
72 0.00 0.00 7.41 0.00 0.00 92.59 
Phenotype categories seen in A+C     
hpf %WT %mild  %moderate %serious %severe %dead 
24 92.12 2.94 0.00 0.00 0.00 0.00 
48 0.00 0.00 32.36 58.06 6.45 3.23 
72 0.00 0.00 0.00 0.00 96.77 3.23 
Phenotype categories seen in C+D     

















Hours	  post	  fertilization	  
Combinations	  
A+C+D	  N=1	  n=24	  C+D	  N=1	  n=30	  A+C	  N=1	  n=31	  A+D	  N=2	  n=27	  






 At 24 hpf the combination treatment with acetaminophen and diphenhydramine 
(A+D) had the lowest percent wild type at 60.60%. The combination treatment with 
acetaminophen, carbamazepine, and diphenhydramine (A+C +D) and the combination 
treatment with carbamazepine and diphenhydramine (C+D) had comparable percent wild 
types at 88.46% and 87.10%, respectively. The combination treatment with 
acetaminophen and carbamazepine (A+C) had the highest percent wild type at 
92.12%.  At 48 hpf combination treatments A+C+D, A+C, and A+D all had percent wild 
types of zero. C+D treatments decreased to 23.33% wild type. At 72 hpf combination 
treatments A+C+D, A+C, and A+D remained at percent wild types of zero while C+D 
treatments decreased even more to 13.33% (Table 4). The combination of A+D was the 
most lethal, as 92.59% of embryos were dead by 72 hpf. The second most lethal 
treatment was the combination of A+C+D as 58.33% of embryos were dead at 72 hpf. 
The third most lethal treatment was C+D as 30.00% of the embryos were dead at 72 hpf. 
However, it’s important to keep in mind that the C+D treatment still had a wild type 
percent of 13.33% at 72 hpf while all other combination treatments had 0%. Lastly, only 
3.23% of embryos were dead by 72 hpf in A+C treatments  (Table 4). 
 
24 87.10 12.90 0.00 0.00 0.00 0.00 
48 23.33 40.00 20.00 13.33 0.00 0.00 
72 13.33 30.00 10.00 13.33 3.33 30.00 
Table 4: Percent of wild type zebrafish embryos in different combination treatments over 
the course of three days.  
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Figure 4: Image of the most common phenotype seen (edema and tail deformities) in 
0.4mg of acetaminophen, 0.4mg of diphenhydramine, and 0.1mg of carbamazepine in 1 
mL of water.  
 
 At 72 hpf 41.67% of the treated embryos had edema and 41.67% of the treated 








5:Image of most common phenotype seen in 0.4 mg of acetaminophen and 0.4 mg 
diphenhydramine in 1 mL of water. 
 
 At 72 hpf, 7.41% of embryos had edema and 7.41% of embryos were less 
pigmented. Figure 5 shows both abnormalities.  
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Figure 6: Image of the most common phenotypes seen in 0.4mg of acetaminophen, and 
0.1mg of carbamazepine in 1 mL of water. 
 
 At 72 hpf, 93.55% of embryos had edema. 93.55% of embryos had small eyes, 
93.55% had less pigment, and 93.55% had tail deformities. 3.23% of embryos were 
extremely deformed. Figure 6 shows an edema, small eyes, less pigment, and a tail 
deformity.  
Figure 7: Image of the most common phenotype seen (edema) in 0.4mg/mL of 
diphenhydramine and 0.1mg/mL of carbamazepine.  
 
 At 72 hpf, 53.33% of embryos had edema. 23.33% of embryos had tail 
deformities. 13.33% of embryos had small eyes and 3.33% of embryos were extremely 
deformed. Figure 7 shows an edema. 
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4. Discussion 
Out of all the individual pharmaceuticals tested, carbamazepine had the most 
detrimental effects on zebrafish embryo development. After 72 hours exposed to T3 
(0.2mg/mL) 35.48% of embryos were dead and there were no wild type phenotypes. 
After 72 hours of exposure to 0.2 mg/mL of diphenhydramine only 13.63% of embryos 
were dead and 40.91% percent of embryos remained wild type. Embryos treated in 
0.2mg/mL of acetaminophen after 72 hours remained alive, with a 74.07% percent wild 
type. Embryos exposed to 0.4 mg/mL of carbamazepine after 72 hours fared even worse 
with 48.28% dead and 0% wild types. This was far worse than effects seen at 72-hour 
exposure to 0.4mg/mL of diphenhydramine (0% wild type and 17.39% dead) or 
0.4mg/mL of acetaminophen (0% wild type and 0% dead). With only this information it 
is appropriate to assume that acetaminophen had the least amount of detrimental effects 
of embryo development; however, combination trials reveal otherwise.  
The combination of 0.4mg/mL of acetaminophen, 0.4 mg/mL of 
diphenhydramine, and 0.1 mg/mL carbamazepine in 1 mL of water proved to be more 
detrimental to development than each of the drug concentrations on their own. After 72 
hours, there were no wild type embryos and 58.33% of the embryos were dead. In 
addition, all other combinations tested were more detrimental to development than each 
drug alone.  
Surprisingly, the combination with all three pharmaceuticals was not the most 
detrimental drug combination. When 0.4mg of acetaminophen and 0.4mg of 
diphenhydramine were combined 92.59% of embryos were dead at 72 hpf and there were 
	   27	  
no embryos without any abnormalities. This result was worse than any results that were 
seen with each separate drug in this combination.  
Yet, other combination experiments provided conflicting results. A mixture of 0.1 
mg carbamazepine and 0.4mg diphenhydramine had 13.33% wild type and 30% dead at 
72 hpf and a mixture of 0.4mg of acetaminophen and 0.1mg of carbamazepine had 3.23% 
of embryos dead at 72 hpf with 0% wild type. The mixture with acetaminophen and 
carbamazepine was not as lethal as 0.1mg of carbamazepine alone as that treatment 
yielded 37.93% wild type and 37.93% dead, but the A+C mixture had 0% wild type 
embryos. However, the A+C mixture was more detrimental than 0.4mg of acetaminophen 
alone. The C+D mixture had a smaller percent wild type than carbamazepine but not 
diphenhydramine, and was more lethal than diphenhydramine alone and almost as lethal 
as 0.1mg carbamazepine alone.  
 One possible explanation as to why A+C and C+D had a lower percent of death 
and a higher percent of wild type embryos is that these treatments only contained 0.5mg 
of total drugs added in 1 mL compared to 0.8mg of total drugs in 1 mL of water in A+D 
treatments. Unfortunately, this does not explain why A+D treatments had worse effects 
on embryos than A+C+D treatments that contained a total of 0.9mg drug in 1mL. In 
addition, A+D treatment did not include carbamazepine, which showed to be the most 
lethal drug out of all three pharmaceuticals. Why is it that the only combination without 
carbamazepine was the most lethal? None of the drugs tested have known interactions so 
it would be unlikely that one combination with two drugs be worse than the others. It will 
be important in future studies to increase the replicate size in order to better understand 
combination effects. In this study water quality was not checked throughout the 
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experiments. For example, it may be possible that the A+D mixture had an unfavorable 
pH for developing zebrafish embryos and that is why the A+D mixture was so toxic. 
Zebrafish require a pH between 6-8 (Sanders, 2009) and the adult zebrafish in our lab are 
kept at a pH of ~7.81. Monitoring water quality through pH should be an important part 
of future studies.  
 It is difficult to say whether acetaminophen or diphenhydramine had more 
negative effects on embryo development due to the conflicting results seen in 
combination treatments. More research should be done to further tease out which single 
pharmaceuticals and combinations are most detrimental to zebrafish embryo 
development. Future studies should test pharmaceuticals together at the same 
concentrations and then with every possible combination of drug and concentration to get 
a more complete picture.  
 As for phenotypic results concerning exposure to a single pharmaceutical, lack of 
pigmentation seen in embryos treated with acetaminophen at 0.4 mg/mL is consistent 
with David & Pancharatna (2009) where embryos exposed to acetaminophen 
concentrations of 5.0 x10-5 mg/mL and 1.0 x10 -4 mg/mL exhibited lack of pigmentation. 
However, lack of pigmentation was not observed in embryos treated with an 
acetaminophen concentration of 1.0x10 -5 mg/mL (David & Pancharatna, 2009).  David 
& Pancharatna (2009) also observed deformed tails, abnormal swimming patterns and 
lack of response to external stimuli in all treatment groups. However, my research 
showed that embryos exposed to 0.4 mg/mL of acetaminophen had no deformed tails, 
while swimming patterns and lack of response to external stimuli were not examined. 
Although significantly smaller eyes were seen in embryos treated with 0.4 mg/mL 
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acetaminophen, no observations of this phenotype were made in David & Pancharatna 
(2009). More research needs be done to determine if smaller eyes are a consistent 
phenotype seen in embryos exposed to high acetaminophen concentrations.  
 Selderslaghs, Blust & Witters (2012), treated zebrafish embryos with 
diphenhydramine at a concentration range of 2.55x10 -3 mg/mL to 9.96x10-2mg/mL and 
found abnormalities in heartbeat, circulation, skeletal structure and swimming behaviors 
at 144 hours post treatment. In my research I found that the most common abnormality in 
embryos exposed only to 0.4mg/mL of DPH was the presence of edema, the second most 
common was tail deformities and the third most common was spinal deformities. 
Heartbeat, circulation, and swimming behavior were not recorded in my experiment. 
However, embryos did show significantly less spontaneous tail movement at 24hpf when 
exposed to diphenhydramine. While this spontaneous movement is not a swimming 
behavior present at 144 hpf, the results of this experiment are supported by Selderslaghs, 
Blust & Witters’s (2012) findings that diphenhydramine, which is known to have 
sedative effects, alters swimming behavior. In addition, deformities in the tail and spine 
are supported by skeletal deformities observed in embryos in the Selderslaghs, Blust & 
Witter’s study (2012).  
 Brandhof & Montforts (2010) treated embryos with carbamazepine at 
concentrations of 0.05mg/mL, 0.1 mg/mL, and 0.2 mg/mL and saw tail deformities at 
0.05 mg/mL, tail deformities and growth retardation at 0.1 mg/mL, and tail deformities, 
heart deformities, and growth retardation at 0.2 mg/mL. In my research, embryos exposed 
to 0.1 mg/mL of carbamazepine also had tail deformities. However edemas, spine 
deformities, and embryos with less pigment were observed while they were absent in the 
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Brandhof & Montforts (2010) study. Lastly, carbamazepine exposure in my experiment 
seemed to cause more embryos to die by 72 hpf at 0.1mg/mL (37.93%) compared to the 
number of embryos that were dead by 72 hpf at 0.1 mg/mL (0%) in Brandhof & 
Montforts (2010) study. This discrepancy may be a result of the exposure to both 
carbamazepine and DMSO, as Brandhof & Montforts used an ultrasonic bath and stirring 
to dissolve carbamazepine. Or this discrepancy may be a result of Brandhof & Montforts 
only using eggs from a single clutch. This experiment performed replicates among 
different clutches, which is important because there can be a “large variability between 
batches of eggs in their sensitivity to toxicants (Brandhof & Montforts, 2010).”  
 There are a few limitations to take into consideration while interpreting results of 
the study. Carbamazepine has been found in surface waters, but since carbamazepine is 
not very soluble in water the drug is also found in sediment (Oetken, Nentwig, LÖffler, 
Ternes, & Oehlmann, 2005). Zebrafish embryos in this study were exposed to 
carbamazepine in water not sediment, so the drug had to be dissolved in DMSO. As a 
result, embryos were also exposed to DMSO. However, not the entire drug dissolved in 
the 1% DMSO solution and the amount of DMSO in the solution could not be increased 
without harming the embryos. Therefore, results concerning exposure to carbamazepine 
may be inconsistent due to the inability of the drug to fully dissolve in solution. Future 
studies may instead fine-tune the amount of DMSO and carbamazepine to get a more 
accurate idea of what this drug can do to developing zebrafish embryos. Future studies 
could also use Brandhof & Montforts (2010) method, which did not utilize DMSO at all, 
for dissolving carbamazepine.  
	   31	  
 Second, the methods used made it impossible for embryos to be exposed to 
pharmaceuticals from the moment they were fertilized up until 72 hpf. Often, 30 minutes 
to 45 minutes would pass before all embryos were all transferred from the spawning 
tanks to their treatment dishes. To better mimic what would be happening in the 
environment, it may be of interest to prepare the drug solution to be used in spawning 
water for future studies.  
 Another limitation was inherent in the methodology to collect diphenhydramine 
spontaneous movement data. After all the embryos were dechorinated, their spontaneous 
movement was measured by recording the amount of times each embryo moved its tail in 
one minute. The controls were always measured first, then treatment 1, treatment 2, 
treatment 3, and lastly treatment 4. In combination experiments where there was only one 
treatment, the control embryo’s movements were recorded first, and then the treatment 
embryo’s movements were measured. Results indicated that treatment groups had 
significantly less spontaneous tail movements. However, was this a result of the order 
that the data was collected in? Did the treatment groups have more time to grow 
accustomed to the shock of being dechorionated and thus move less? Did the treatment 
groups move less because more time had passed by the time their movements were 
recorded compared to the treatment groups? It is important to keep in mind that 
spontaneous movement behavior is only present in embryos 18-26 hpf, and it may be that 
movement is different at 18 hpf compared to 19 hpf. To isolate the effects of 
diphenhydramine from the effects time may have had on spontaneous movement it would 
be beneficial to record movement in a video and then record the data in order to ensure 
embryos are being compared at the same moment time. Lastly, spontaneous movement 
	   32	  
data collected at 24 hpf for the control, T1, T2, T3, and T4 was not from the same clutch 
of embryos that provided phenotypic data. This was because embryos that provided data 
for spontaneous movement at 24 hpf were dead on day two of the experiment so their 
phenotypes were not recorded. Since DPH experiments where phenotypes were recorded 
did not have all embryos dead by day two, it can be assumed that the clutch of eggs used 
to record movement data were not healthy. This lack of health may have contributed to 
less movement overall for all treatment groups.  Although combination results indicated 
that exposure to more pharmaceuticals did not significantly decrease spontaneous tail 
movements, this may not be true especially if the embryos in the T4 group were not 
healthy to begin with. In the future it would be best to use the same clutch of eggs for 
spontaneous movement data and phenotypic data.  
 While collecting eye size data for embryos treated with acetaminophen and 
diphenhydramine the majority of embryos were dead by day three. This left a sample size 
of 2. More trials should be done to increase the sample size in order to properly compare 
eye size across all experiments containing acetaminophen.  
 Phenotypic results and categories were completely subjective. As with anything 
that is subjective there is room for error and discrepancies. Future studies may want to 
solely research quantitative aspects of zebrafish development such as heartbeat, eye size, 
spontaneous movement, etc.  
Lastly, the concentrations that were studied are much higher than what is actually 
in surface waters in the United States. However, the concentrations in the environment 
will continue to rise. In the environment carbamazepine has been reported as having 
concentrations up to 2.2 x10-12 mg/mL. The concentration used in combination treatments 
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(0.1mg/mL) is 4.54x1010 times higher than what is found in the environment. 
Acetaminophen combination treatments used a concentration of 0.4mg/mL, which is 
3.63x109 times higher than what is found in the environment (1.1x10-10 mg/mL). Lastly, 
diphenhydramine concentrations (0.4 mg/mL) used in combination treatments are 
6.66x104 times higher than what is found in the environment (6.0x10-6 mg/mL).  
While this is somewhat encouraging because these phenotypic effects most likely 
will not be seen in the environment, it is still of extreme importance to understand exactly 
what is happening in the environment. Future studies should test drugs in combination at 
their environmental concentrations. It would also be beneficial to grow a clutch of 
zebrafish embryos in conditions that are equal to drug concentrations in the environment 
to study any effects the combination of drugs may have on future generations. In 
addition, only three out of the 51 pharmaceuticals found entering Lake Champlain were 
studied in this experiment. Therefore, it is important to determine how the remaining 48 
pharmaceuticals in the lake may be affecting aquatic development alone and in 
combination. These studies must be done in order to provide a necessary wake up call to 
update wastewater treatment systems before pharmaceuticals in effluent becomes too 
toxic and to protect our environment.  
5. Conclusions 
Overall, the goals of this experiment were reached. Sub-lethal concentrations 
were determined for acetaminophen, diphenhydramine, and carbamazepine. Once 
combined, the mixture of the three pharmaceuticals proved to be more detrimental to 
developing zebrafish embryos than each of the pharmaceuticals alone. However, when 
pharmaceuticals were combined in groups of two the results ended up being quite 
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conflicting as the acetaminophen and diphenhydramine combination was more 
detrimental than the combination of the three pharmaceuticals. Since replicates in 
combination experiments were low and water quality was not monitored more research 
should be done to be certain that this is true, and if it is, why that may be.  
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